Correlation Between GlaxoSmithKline PLC and Biomarin Pharmaceutical
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Biomarin Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Biomarin Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Biomarin Pharmaceutical, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Biomarin Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Biomarin Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Biomarin Pharmaceutical.
Diversification Opportunities for GlaxoSmithKline PLC and Biomarin Pharmaceutical
0.85 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between GlaxoSmithKline and Biomarin is 0.85. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Biomarin Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biomarin Pharmaceutical and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Biomarin Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biomarin Pharmaceutical has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Biomarin Pharmaceutical go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and Biomarin Pharmaceutical
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Biomarin Pharmaceutical. In addition to that, GlaxoSmithKline PLC is 1.0 times more volatile than Biomarin Pharmaceutical. It trades about -0.23 of its total potential returns per unit of risk. Biomarin Pharmaceutical is currently generating about -0.06 per unit of volatility. If you would invest 6,668 in Biomarin Pharmaceutical on August 31, 2024 and sell it today you would lose (126.00) from holding Biomarin Pharmaceutical or give up 1.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. Biomarin Pharmaceutical
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| Biomarin Pharmaceutical |
GlaxoSmithKline PLC and Biomarin Pharmaceutical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and Biomarin Pharmaceutical
The main advantage of trading using opposite GlaxoSmithKline PLC and Biomarin Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Biomarin Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biomarin Pharmaceutical will offset losses from the drop in Biomarin Pharmaceutical's long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| Biomarin Pharmaceutical vs. Alnylam Pharmaceuticals | Biomarin Pharmaceutical vs. Exelixis | Biomarin Pharmaceutical vs. Halozyme Therapeutics | Biomarin Pharmaceutical vs. Arrowhead Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |